Prognostic Implications of Time between Balloon to Peak Creatinine Kinase-MB in patients with Acute Myocardial Infarction Undergoing Primary PCI: Multicenter Cohort Study

Time from acute percutaneous coronary angioplasty to maximum serum CK-MB level and clinical outcome in patients with acute myocardial infarction - Time from acute percutaneous coronary angioplasty to maximum serum CK-MB level and clinical outcome in patients with acute myocardial infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049942

Enrollment

1000

Registered

2022-12-28

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: (1) did not undergo primary PCI, (2) the onset of AMI is unknown, and (3) plasma CK levels were already at peak at admission.

Design outcomes

Primary

Measure	Time frame
cardiovascular death at 1 year	—

Countries

Japan

Contacts

Public ContactEiji Shibahashi

Department of Cardiology, Tokyo Womens Medical University, Tokyo, Japan Cardiology

shibahashi.e@gmail.com03-3353-8111

Outcome results